Polymorphism of the tumor necrosis factor-α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients

Diabetes Care

Volumn 23, Issue 6, 2000, Pages 831-837

  Fernández Real, José Manuel ^a   Vendrell, Joan ^b   Ricart, Wifredo ^a   Broch, Montserrat ^b   Gutiérrez, Cristina ^b   Casamitjana, Roser ^c   Oriola, Josep ^c   Richart, Cristóbal ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ALLELE; ARTICLE; DIET THERAPY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0042049485     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.6.831     Document Type: Article

References (46)

1. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
2. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, Bryer-Ash M: An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signalling by TNF-alpha. Endocrinology 139:4928-4931, 1998
3. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
4. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
6. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
7. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White ME, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TKF-alpha-and obesity-induced insulin resistance. Science 271: 665-668, 1996
8. Ventre J, Doebber T, Wu M, Macnaul K, Stevens K, Pasparakis M, Kollias G, Moller DC: Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531, 1997
9. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614, 1997
10. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962, 1994
11. Schreyer SA, Chua SC, LeBoeuf RC: Obesity and diabetes in TKF-alpha receptor-deficient mice. J Clin Invest 102:402-411, 1998
12. Uysal KT, Wiesbrock SM, Hotamisligil GS: Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139:4832-4838, 1998
13. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effect of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
14. Fernández-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J, Soler J, Richart C: The TNF-alpha Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468-1472, 1997
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199, 1997
16. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F: Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28:59-66, 1998
17. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455, 1997
18. Engelmann HD, Aderka D, Rubinstein M, Rotman D, Wallach D: A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264:11974-11980, 1989
19. Nophar Y, Kemper O, Brakebusch G, Engelmann H, Zwang R, Aderka D, Holtmann H, Wallach D: Soluble forms of tumor necrosis factors (TNF-Rs): the cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278, 1990
20. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992
21. Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C: Plasma levels of the soluble fraction of tumor necrosis factor alpha receptor 2 and insulin resistance. Diabetes 47:1757-1762, 1998
22. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: a role lor leptin in the anorexia of infection. J Clin Invest 97:21 52-21 57, 1996
23. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
24. Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA: Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 246:660-667, 1998
25. Zumbach MS, Bochme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP: Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82: 4080-4082, 1997
26. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Grivcas I, Katsilambros N, Flier JS: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82: 3408-3413, 1997
27. Moller N, O'Brien P, Nair KS: Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab 83:931-934, 1998
28. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varicchio M, D'Onofrio F: Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 275 (2 Pt. 1): E294-E299, 1998
29. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fuji M, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1998
30. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG: Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84:272-278, 1999
31. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
32. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 79:790-800, 1987
33. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW: Reagent lor the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29: 1075-1080, 1983
34. Kostner GM, Molinari E, Pichler P: Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chim Acta 148:139-147, 1985
35. Wahlefeld AW: Lipoproteins. In Methoden der Enzymatischen Analyse Vol. 2, 3rd ed. Bergmeyer HU, Ed. Weinheim, Germany, Verlag Chemie, 1974, p. 187-188
36. Kaufman BA, White PS, Brodeur G: A complex single strand conformational polymorphism (SSGP) in the tumor necrosis factor receptor 2 (TNFR2) gene on chromosome 1p36.2. Hum Mol Genet 2:824, 1993
37. Kaufman BA, While PS, Stembrueck T, Donis-Keller H, Brodeur GM: Linkage mapping of the tumor necrosis factor receptor 2 (TNFR2) gene to 1p36.2 using the single strand conformation polymorphism technique. Hum Genet 94:418-422, 1994
38. Baker E, Chen LZ, Smith CA, Cullen DF, Goodwin R, Sutherland GR: Chromosomal location of the human tumor necrosis factor receptor genes. Cytogenet Cell Genet 57: 117-118, 1991
39. Chagnon YC, Perusse L, Lamothe M, Chagnon M, Nadeau A, Dionne FT, Gagnon J, Chung WK, Leibel RL, Bouchard C: Suggestive linkages between markers on human 1p32-p22 and body fat and insulin levels in the Quebec Family Study. Obes Res 5:115-121, 1997
40. Chagnon YC, Perusse L, Bouchard C: The human obesity gene map: the 1997 update. Obes Res 6:76-92, 1998
41. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H: Selective upregulation of the 75-kDa tumor necrosis (TNF) receptor and its mRNA by TNF and IL-I. J Immunol 150: 4346-4353, 1993
42. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG: Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138:3395-3401, 1997
43. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L: Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 100:3105-3110, 1997
44. Koyama K, Chen G, Wang M-Y, Lee Y, Shimabukuro M, Newgard CB, Unger RH: β-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 46:1276-1280, 1997
45. Fernández-Real JM, Casamiljana R, Ricart W: Leptin is involved in gender related differences in insulin sensitivity. Clin Endocrinol 49:505-512, 1998
46. Peraldi P, Spiegelman B: TNF-α and insulin resistance: summary and future prospects. Mol Cell Biochem 182:169-175, 1998